131 related articles for article (PubMed ID: 28528451)
21. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264
[TBL] [Abstract][Full Text] [Related]
22. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients.
DeMichele A; Putt M; Zhang Y; Glick JH; Norman S
Cancer; 2003 May; 97(9):2150-9. PubMed ID: 12712466
[TBL] [Abstract][Full Text] [Related]
23. Association between comorbidity and participation in breast and cervical cancer screening: A systematic review and meta-analysis.
Diaz A; Kang J; Moore SP; Baade P; Langbecker D; Condon JR; Valery PC
Cancer Epidemiol; 2017 Apr; 47():7-19. PubMed ID: 28086199
[TBL] [Abstract][Full Text] [Related]
24. 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Pivot X; Romieu G; Debled M; Pierga JY; Kerbrat P; Bachelot T; Lortholary A; Espié M; Fumoleau P; Serin D; Jacquin JP; Jouannaud C; Rios M; Abadie-Lacourtoisie S; Tubiana-Mathieu N; Cany L; Catala S; Khayat D; Pauporté I; Kramar A;
Lancet Oncol; 2013 Jul; 14(8):741-8. PubMed ID: 23764181
[TBL] [Abstract][Full Text] [Related]
25. Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients.
Farag S; van Coevorden F; Sneekes E; Grunhagen DJ; Reyners AKL; Boonstra PA; van der Graaf WT; Gelderblom HJ; Steeghs N
Eur J Cancer; 2017 Nov; 86():318-325. PubMed ID: 29073582
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis.
Kelly AM; Dwamena B; Cronin P; Carlos RC
Acad Radiol; 2009 May; 16(5):551-63. PubMed ID: 19345896
[TBL] [Abstract][Full Text] [Related]
27. The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis.
Raphael MJ; Biagi JJ; Kong W; Mates M; Booth CM; Mackillop WJ
Breast Cancer Res Treat; 2016 Nov; 160(1):17-28. PubMed ID: 27632288
[TBL] [Abstract][Full Text] [Related]
28. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
Gennari A; Sormani MP; Pronzato P; Puntoni M; Colozza M; Pfeffer U; Bruzzi P
J Natl Cancer Inst; 2008 Jan; 100(1):14-20. PubMed ID: 18159072
[TBL] [Abstract][Full Text] [Related]
29. Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.
Mghanga FP; Lan X; Bakari KH; Li C; Zhang Y
Clin Breast Cancer; 2013 Aug; 13(4):271-9. PubMed ID: 23714689
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
Vera-Badillo FE; Templeton AJ; de Gouveia P; Diaz-Padilla I; Bedard PL; Al-Mubarak M; Seruga B; Tannock IF; Ocana A; Amir E
J Natl Cancer Inst; 2014 Jan; 106(1):djt319. PubMed ID: 24273215
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.
Yan T; Yin W; Zhou Q; Zhou L; Jiang Y; Du Y; Shao Z; Lu J
Eur J Cancer; 2012 Jan; 48(2):187-95. PubMed ID: 22100904
[TBL] [Abstract][Full Text] [Related]
32. Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review.
Carroll J; Protani M; Walpole E; Martin JH
Breast Cancer Res Treat; 2012 Nov; 136(2):323-30. PubMed ID: 22918525
[TBL] [Abstract][Full Text] [Related]
33. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
Gross CP; McAvay GJ; Guo Z; Tinetti ME
Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973
[TBL] [Abstract][Full Text] [Related]
34. Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer.
Yuan Y; Vora N; Sun CL; Li D; Soto-Perez-de-Celis E; Mortimer J; Luu TH; Somlo G; Waisman J; Smith D; Chao J; Katheria V; Synold T; Tran V; Mi S; Levi A; Arsenyan A; Choi J; Zavala L; Yost S; Hurria A
Breast Cancer Res; 2017 Aug; 19(1):101. PubMed ID: 28851415
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
[TBL] [Abstract][Full Text] [Related]
36. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Zauderer M; Howard J; Hudis C
Breast Cancer Res Treat; 2005 Jul; 92(2):151-6. PubMed ID: 15986124
[TBL] [Abstract][Full Text] [Related]
37. The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures.
Du Y; Zhou Q; Yin W; Zhou L; Di G; Shen Z; Shao Z; Lu J
Breast Cancer Res Treat; 2011 Oct; 129(3):839-48. PubMed ID: 21809115
[TBL] [Abstract][Full Text] [Related]
38. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
Lee YC; Hsieh CC; Chuang JP; Li CY
Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
[TBL] [Abstract][Full Text] [Related]
39. The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: a systematic review and meta-analysis.
Boakye D; Nagrini R; Ahrens W; Haug U; Günther K
Ther Adv Med Oncol; 2021; 13():1758835920986520. PubMed ID: 33613694
[TBL] [Abstract][Full Text] [Related]
40. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
